Verastem Oncology
VSTM
$9.38
Share price
1.79%
Change (1 day)
2,305.13%
Change (1 year)
Categories
Verastem Oncology (VSTM) Fails to deliver data
Key failure to deliver metrics for Verastem Oncology :
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.04 M
- Last 3 months FTD volume: $0.45 M
- Last year FTD volume: $6.07 M
Failures to deliver for Verastem Oncology (VSTM) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Verastem Oncology (VSTM) - since 2023
Volume in USD (price x number of shares), data since 2023Verastem Oncology (VSTM) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.45 M | -92% |
| 2023 | $5.62 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Pfizer PFE | $31.87 M | $0.32 B | 🇺🇸 USA |
 LabCorp LH | $18.16 M | $53.7 M | 🇺🇸 USA |
 GlaxoSmithKline GSK | $15.53 M | $26.02 M | 🇬🇧 UK |
 Curis CRIS | N/A | $1.02 M | 🇺🇸 USA |